Home » Investors » Financials » Quarterly Figures

Quarterly Figures

Quarterly Figures

MSEKApril-June 2025Jan-Mar 2025Oct-Dec 2024July-Sept 2024April-June 2024Jan-Mar 2024Oct-Dec 2023July-Sept 2023April-June 2023
Net sales324.2334.7515.1369.1423.3419.6516.5466.4412.2
Organic growth, %-17.0%-21.8%-0.6%-17.7%1.3%5.4%-11.2%-1.3%-15.2%
Gross profit*142.4189.7308.0200.3221.6192.2268.2253.4179.6
Gross margin*, %43.9%56.7%59.8%54.3%52.3%45.8%51.9 %54.3 %43.6 %
Operating income before depreciation and amortization (EBITDA)-52.5-21.4107.54.313.4-22.182.461.9128.3
EBITDA margin, %-16.2%-6.4%20.9%1.2%3.2%-5.3%16.0%13.3%31.1%
Operating profit (EBIT)-105.4-77.9-8.3-64.3-49.6-178.9-215.8-24.1-162.3
Operating margin (EBIT), %-32.5%-23.3%-1.6%-17.4%-11.7%-42.6%-41.8%-5.2%-39.4%
Net profit/loss from continuing operations-181.7-235.4250.5-260.8-81.2-18.6-460.3-38.5-111.5
Cash flow from operating activities-28.276.6181.645.0-50.9-17.3162.03.6-47.7
Average number of shares70 574 89570 574 89570 574 89570 574 89570 574 89570 574 89570 574 89570 574 89570 574 895
Number of shares at closing day70 574 89570 574 89570 574 89570 574 89570 574 89570 574 89570 574 89570 574 89570 574 895
Earnings per share after dilution, SEK-2.55-3.323.56-3.68-1.14-0.25-6.51-0.55-1.58
Share price at closing day, SEK363132454447573039
Market cap at closing day, BSEK2.52.22.33.13.13.34.02.12.8
Average number of employees at closing day in continuing operations599606621627642648691717746
All numbers on this page refers to Ginolis being classified as discontinued operations from the Q4 2023, Nanoscribe from Q4 2024 and Mattek and Visiokol from Q2 2025 with retroactive effect. * From Q1 2024, BICO has changed to functional reporting with retroactive effect, mainly impacting the reporting of gross profit and gross margin compared to prior periods.

Contact us!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.